UNSPSC 51291803: Moclobemide

This classification denotes a monoamine oxidase inhibitor with the molecular formula C13H17ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PJ0Y7AZB63, chemically known as benzamide, 4-chloro-n-(2-(4-morpholinyl)ethyl)- but generally known as moclobemide, which bears US NIH Compound Identifier 4235. European Medicines Agency schedules Moclobemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09024MIG.

UNSPSC 51291803 Moclobemide, a Commodity code, shows limited recent state and local procurement activity aligned with the pharmaceutical-product scope of the code itself. The single recent opportunity in the dataset is Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, which solicits naloxone and safe drug deactivation systems—opioid-reversal and controlled-substance disposal products—rather than moclobemide, a monoamine oxidase inhibitor antidepressant. The mismatch between the code's nominal pharmaceutical scope and the actual products being procured suggests either tagging error or administrative recategorization by the issuing body. State and local health agencies and counties appear to be the primary buyers under this commodity when activity does occur, though the recent opportunities block reflects minimal solicitation volume under the specific code designation.

The Seminole County procurement represents the only recent signal in the data. The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB process closed July 26, 2023, at 2:00 pm; vendors were required to include all shipping and delivery costs in their bids and comply with E-Verify and drug-free workplace certification. The contract carried a two-year initial term with one-year renewal option and included potential FEMA funding, triggering federal compliance overlays such as the Clean Air Act and Federal Water Pollution Control Act. The procurement shows no explicit set-aside designations for disadvantaged enterprises. Given the sparse recent activity and the mismatch between code designation and actual procurement, this commodity warrants a watch-and-verify posture rather than active pursuit until more aligned recent opportunities emerge.